6 Results for "

HUDEP-2

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "HUDEP-2" in MCE Product Catalog:

Cat. No.: HY-175742
CAS No.: 3036554-12-5
BMS-986470, a HbF-activating CRBN E3 ligase modulator (CELMoD), is an orally active dual molecular glue degrader targeting ZBTB7A and WIZ. BMS-986470 has potent γ-globin induction activity. BMS-986470 can be used for sickle cell disease (SCD) research .
loading...
    loading...
Cat. No.: HY-152775
CAS No.: 2648855-18-7
Purity:  98.04%
Research Areas:  

Cancer

RK-701 is an highly selective and non-genotoxic inhibitor of G9a with IC50 value of 23-27 nM. RK-701 selectively up-regulates HbF, γ- Globin, BGLT3 expression, down-regulates H3K9me2 expression. RK-701 also has inhibition for BCL11A and ZBTB7A .
loading...
    loading...
Cat. No.: HY-147099
Purity:  97.8%
Target:  

PROTACs FKBP

Research Areas:  

Cancer

dTAG-47-NEG is an inactive bifunctional negative control PROTAC and also the diastereomer of dTAGV-1 (HY-145514D). dTAG-47-NEG does not reduce the level of BCL11A-FKBP12 F36V, nor does it induce the degradation of BCL11A-FKBP12 F36V, proteins tagged with FKBP12 F36V, wild-type FKBP12, FKBP12 F36V-KRAS G12V or FKBP12 F36V-EWS/FLI. dTAG-47-NEG exerts no antiproliferative effect in cancer cells [2] .
loading...
    loading...
Cat. No.: HY-152775A
Research Areas:  

Metabolic Disease

RK-0133114 is a G9a inhibitor and a R-enantiomer of RK-701 (HY-152775). RK-0133114 inhibits G9a with an IC50 value of 3.7 μM. RK-0133114 can be used for the research of sickle cell disease (SCD) .
loading...
    loading...
Cat. No.: HY-161787
CAS No.: 2648853-26-1
Research Areas:  

Others

G9a-IN-2 (Compound 7i) is an inhibitor for histone methyltransferases G9a with IC50 of 0.024 μM. G9a-IN-2 reduces H3K9me2 levels and induces the mRNA expression of γ-globin mRNA. G9a-IN-2 shows the potential in ameliorating sickle cell disease (SCD) .
loading...
    loading...
Cat. No.: HY-172894
Research Areas:  

Cardiovascular Disease Cancer

G9a-IN-3 (compound 16g) is a potent G9a inhibitor with an IC50 of 0.002 μM. G9a-IN-3 can be used in the study of sickle cell disease .
loading...
    loading...